• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Babesia and Bacterial Contamination Most Frequent Transfusion-Transmitted Infections

January 30, 2019

Based on hemovigilance data from the National Healthcare Safety Network (NHSN), viral transfusion-transmitted infections (TTI) are rare while bacterial contamination of platelets and transfusion-transmitted babesiosis occur more frequently. The NHSN Hemovigilance Module began monitoring infections associated with transfusions in January 2010.  Based on data from 308 facilities which transfused 7.9 million blood components over 6 years, 111 TTIs were reported.  Of the 111 TTIs, 54 were confirmed .  Almost 70% of the confirmed TTIs were bacterial (37/54); 30% (16/54) were Babesia TTIs (the only parasitic specie reported); and one case (2%) was viral (hepatitis C virus).  The rate of bacterial contamination of platelets was 1.95 per 100,000 transfused (26 from apheresis and 4 from whole blood) compared to 0.68 TTI for all transfused components . Staphylococcus aureus was the most commonly reported bacteria.  Bacterial contamination of platelets and Babesia in RBCs  should be targeted for interventions in order to further reduce TTIs.

Reference:

  1. Haass KA, Sapiano MRP, Savinkina A, Kuehnert MJ, and SV Basavaraju. Transfusion-transmitted infections reported to the National Healthcare Safety Network Hemovigilance Module. Transfusion Medicine Reviews 2019

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Variability of Blood Donor Incentives Globally

  • The FDA Approves Cerus’s Intercept System for Platelets and Plasma

  • High Variability in Antibody Titer Determination in Transfusion Medicine

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley